Testimonials need paperwork, before-and-after imagery gets rejected at upload, and attribution breaks on the phone. Here is what actually happens to the budget when the standard creator motion meets a regulated category.
By Steve Bunker, CEO, Target Patients MD
A skincare brand partners with a creator, sends product, gets a review video, and the whole thing works because the creator can say what happened to their skin. Same category, same audience, same content format — but move the transaction from a serum to a clinic that injects something, and most of that playbook becomes unusable.
This is not a small carve-out. Aesthetics, dentistry, weight management, dermatology, and wellness clinics represent a large and growing share of the businesses that want creator partnerships, and they operate under rules that do not apply to the brands sitting next to them in a creator’s inbox. Anyone building influencer programs across consumer categories will eventually be handed a healthcare client, and the instinct to run the standard motion is the thing that causes problems.
What follows is not a compliance lecture. It is an account of which specific mechanics break, why, and what practices end up doing with the budget instead — because the second part is where the interesting strategic shift lives.
The testimonial problem is bigger than it looks
Start with the format that does the most work in creator marketing: someone describing their own experience with a product or service. In most categories this is unremarkable. In healthcare it is a regulated act.
When a person receives treatment at a medical or dental practice and then talks publicly about it, they are disclosing their own health information — which they are entitled to do. The constraint sits on the practice. A clinic that reposts, amplifies, or pays for that content is participating in a disclosure about a patient, and doing so requires written authorization that specifies what is being used and where it will appear.
The word "written" carries weight. A creator agreeing enthusiastically in a DM is not authorization. Neither is a general model release signed at intake, if it does not contemplate paid social distribution. Practices that treat this as a formality discover the gap when a campaign is already running, and the remedy is usually pulling the creative down.
There is a second-order effect that catches brands off guard. Authorization is specific to the channels named in it. Content approved for a practice’s own social feed is not automatically cleared for a paid ad, a website gallery, or a repost by the creator’s agency. Programs that scale across placements need the paperwork to scale with them, and the paperwork has to exist before the first placement, not after the third.
The best-performing creative is the most constrained
Visual before-and-after content is the single most persuasive asset in aesthetic marketing. It is also the most tightly governed, and the governance comes from three directions at once.
There is the authorization requirement already described. There are professional advertising standards, which vary by state and by board, and which generally restrict imagery that implies a typical or guaranteed result. And there are platform policies — the major social advertising platforms maintain specific rules about before-and-after imagery in ads for health and body-related products, and enforcement is automated and unforgiving.
The practical consequence for a creator program is that the content the creator most wants to make is the content most likely to be rejected, either by the platform at upload or by the practice’s own counsel before it gets that far. Teams that plan a campaign around transformation content and discover this in week three lose the campaign, not just the asset.
Practices that navigate it well tend to shift the creative brief away from outcomes and toward process — what the consultation is like, what the recovery involves, what the practitioner explains and why. That content is less immediately arresting and considerably more durable, and it happens to answer the questions prospective patients actually have.
Three disclosure regimes, not one
Creator marketing already operates under advertising disclosure requirements. Healthcare adds two more layers that stack rather than substitute.
The first is the material connection disclosure everyone in this industry knows — a creator paid or given something of value has to make that relationship clear. The second is professional: many jurisdictions have rules about how medical and dental services may be advertised, including who may make clinical claims and how credentials are represented. The third is platform policy, which frequently treats health-adjacent advertising as a restricted category with its own approval process.
These do not resolve into a single checklist, and they do not always agree about placement, wording, or prominence. A disclosure that satisfies advertising standards may still leave a clinical claim unsupported. A caption that satisfies a professional board may not meet a platform’s formatting requirement.
For agencies, the workable posture is treating healthcare partnerships as their own workflow rather than a variant of the standard one — different intake, different approvals, different review step before anything publishes. Attempting to run them through the general process is where most of the failures originate.
What creators should ask before accepting a healthcare partnership
This cuts both ways, and the creator side of it gets discussed less than it should.
A creator taking a clinic partnership is being asked to describe a medical or dental experience to an audience that may act on it. That carries exposure the creator usually has not thought about — reputationally if outcomes vary, and practically if the brief asks them to say something a clinician would not.
The questions worth asking are simple. Who wrote the claims in the brief, and is a licensed practitioner willing to stand behind them. What authorization has been signed, and does it cover what the creator is being asked to publish. What happens if the platform rejects the content. And whether the creator is being asked to describe a personal experience they actually had, or to present someone else’s outcome as their own.
Creators who ask these questions get better briefs. The ones who do not tend to end up in the middle of a problem they did not create.
Where the budget actually goes
Here is the part that matters strategically, and it is the reason healthcare marketing looks so different from the outside.
When the most efficient acquisition channels are constrained — when retargeting a person who read about a condition is a regulatory question, when testimonial content requires paperwork, when the highest-converting imagery may be rejected at upload — the money moves to the channels that do not have those problems. Overwhelmingly that means owned assets: the practice’s own website, its own search visibility, and its own content answering the questions people are already typing.
This is why practices frequently spend more on their website than a comparable consumer business would, and why questions about medical website design cost surface so early in the planning conversation. The line items are not the ones a consumer brand budgets for: compliant consent capture on every form, a before-and-after gallery that can hold the authorization behind each image, landing pages built to convert a phone call rather than a cart, and analytics configured under an agreement that covers protected health information. The site is not a brochure supporting the campaign. In a constrained category it is closer to the primary channel, because it is the one surface where the practice controls the claims, the compliance posture, and the conversion path without a platform between them and the patient.
That reallocation has a knock-on effect on creator programs. Where partnerships do run, they tend to be used for reach and familiarity rather than for direct response, with conversion handled on owned property where the rules are manageable. Creators drive people to look; the site does the work of turning that into a booking.
It also changes what a practice is willing to pay for. A creator partnership that generates awareness it cannot convert is a poor buy for a clinic in a way it is not for an ecommerce brand with a frictionless checkout. Programs pitched on impressions rarely survive the second budget cycle.
The measurement problem nobody mentions
There is one more break in the standard playbook, and it is the one that most often turns a healthcare creator program into an argument three months in: you frequently cannot measure it the way you would measure anything else.
Attribution in consumer categories relies on following a person from exposure to purchase. In healthcare, the scripts and pixels that make that possible collect information about people seeking care, and whether that data falls under health privacy rules is a live question that regulators and courts have been working through rather than settling. Practices with cautious counsel restrict what runs on their pages, and the restriction lands hardest on exactly the tracking a creator campaign would use to prove its value.
The other half of the problem is the phone. A large share of the highest-intent contact a practice receives arrives as a call, and a call produces almost no signal in a standard analytics setup. Someone sees a creator’s post, thinks about it for a week, searches the practice by name, and dials. The dashboard records a branded search and attributes nothing to the campaign that created the demand.
The consequence is that creator programs in this category are frequently underrated by the measurement, not by the market. Practices that judge them on last-click attribution cancel campaigns that were working. The ones that get value from them measure at the level of total qualified contact over a period, run holdouts when the spend justifies it, and ask new patients an open question about how they heard — which returns answers no report contains.
For agencies pitching these programs, that is worth raising before the contract rather than in month three. A client expecting a clean attribution story will be disappointed by a channel that cannot produce one, however well it performed.
The pattern generalizes to every regulated category
None of this is unique to medicine, though medicine is where it is most acute.
Financial services faces its own version — claims about returns are constrained, testimonials about outcomes carry specific requirements, and creator content is subject to review processes that do not exist in consumer goods. Supplements sit under structure-function claim rules that quietly prohibit most of what a creator would naturally say. Legal services operate under bar advertising rules that vary by state and restrict comparative and outcome-based claims.
The shared structure is worth naming: in regulated categories, the persuasive burden shifts from the endorsement to the evidence. What a creator can say is limited, so what the brand can demonstrate becomes the differentiator. That pushes budget toward owned content, transparent information, and identifiable expertise — and away from the borrowed credibility that makes influencer marketing efficient elsewhere.
For anyone building programs in these categories, the useful instinct is to ask early what the brand is permitted to claim, rather than designing the campaign first and discovering the constraints during review. The constraint is not a detail to be handled at the end. It determines what kind of campaign is possible at all.
What good looks like
Practices and agencies that run healthcare creator programs successfully share a few habits, none of them complicated.
They handle authorization before creative, not after, and they write it broadly enough to cover every placement the program might reach. They brief creators on process rather than outcomes, which sidesteps most of the claim and imagery problems at the point where they are cheapest to avoid. They keep a licensed practitioner in the approval chain, because a clinician catching an unsupportable claim in a draft costs nothing and catching it after publication costs a great deal.
And they build the owned side first. A campaign that drives attention to a site that cannot answer the questions it raised converts poorly regardless of how good the creative was — and in a category where you cannot retarget the visitor who left, that first visit carries more weight than it does anywhere else.
The constraint is real and it is not going away. What it produces, in the practices that adapt to it rather than fight it, is a marketing operation built on things the business actually controls. That is a more durable position than most consumer brands occupy, and it was arrived at entirely by necessity.
Steve Bunker is CEO of Target Patients MD, a marketing agency working exclusively with medical and dental practices across the United States and Canada.
Comments
Loading comments…